Medicines Updates and Statements

11.15.2019

Pfizer Announces CHMP Opinion for XELJANZ® (tofacitinib) in the European Union Related to Ongoing Review of the Product

06.04.2018

Hospira Issues A Voluntary Nationwide Recall For Two Lots of Naloxone Hydrochloride Injection, USP, in the Carpuject™ Syringe System Due To The Potential Presence of Particulate Matter.

05.09.2018

Important Notice Regarding EpiPen auto-injector supply

03.05.2018

Hospira Issues A Voluntary Nationwide Recall For Hydromorphone HCL Injection, USP CII Due To The Potential For Empty Or Cracked Glass Vials

02.23.2018

Hospira Issues A Voluntary Nationwide Recall For Labetalol Hydrochloride Injection, USP, Due To The Potential Of Cracked Glass At The Rim Surface Of The Vials